FDA approves raplixa for controlling bleeding during surgery
from Anesthesiology News
The FDA has approved both Raplixa (fibrin sealant, ProFibrix BV) and the RaplixaSpray device (The Medicines Company) for controlling mild to moderate bleeding during surgery. Raplixa is indicated for use in adults to help control bleeding from small blood vessels when sutures, ligature and other standard surgical techniques are ineffective or impractical, according to the FDA. Raplixa contains fibrinogen and thrombin. When this biological product is dissolved in the blood, it causes a reaction between these two proteins to form blood clots to help stop the bleeding.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063